Comment on “Drug survival of apremilast for psoriasis in a real-world setting”

dc.contributor.author	Santos-Juanes Jiménez, Jorge
dc.contributor.author	Velasco, Lucía
dc.contributor.author	Munguía Calzada, Pablo
dc.contributor.author	Lozano, Ana
dc.contributor.author	Gómez Díez, Santiago Francisco
dc.date.accessioned	2019-01-30T07:57:28Z
dc.date.available	2019-01-30T07:57:28Z
dc.date.issued	2018
dc.identifier.citation	Journal of the American Academy of Dermatology, 79(4), p. e83- (2018); doi:10.1016/j.jaad.2018.05.1254
dc.identifier.issn	0190-9622
dc.identifier.uri	http://hdl.handle.net/10651/49746
dc.format.extent	p. e83-
dc.language.iso	eng
dc.relation.ispartof	Journal of the American Academy of Dermatology
dc.rights	© 2018 by the American Academy of Dermatology, Inc.
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053436021&doi=10.1016%2fj.jaad.2018.05.1254&partnerID=40&md5=950061d4d22bf01b02f904da37a50e4e
dc.title	Comment on “Drug survival of apremilast for psoriasis in a real-world setting”
dc.type	journal article
dc.identifier.doi	10.1016/j.jaad.2018.05.1254
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.jaad.2018.05.1254

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.